Latest Amgen News & Updates

See the latest news and media coverage for Amgen. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Amgen

Multinational biopharmaceutical company

amgen.com
Headquarters
Thousand Oaks, United States
Founded year
1980
Company type
Public company
Number of employees
40,000+

Latest news about Amgen

Company announcements

  • Amgen

    Amgen's Shannon Turley inducted into National Academy of Sciences

    She receives top U.S. honor for immunology and oncology research impacting cancer immunotherapies. As VP of Research, she advances drug discovery.

  • Amgen

    Amgen shares 2026 Q1 earnings highlights

    16 brands achieve double-digit growth. CEO confident in long-term growth amid patent expirations and competition.

  • Amgen

    Amgen reports Q1 2026 financial results

    Total revenues rose 6% to $8.6 billion. GAAP EPS increased 4% to $3.34. Non-GAAP EPS grew 5% to $5.15. Free cash flow reached $1.5 billion.

  • Amgen

    Amgen announces webcast for 2026 Q1 results

    Amgen will report results April 30, 2026 after market close, hold a 4:30 p.m. ET conference call, and provide an archived webcast for at least 90 days.

Unlock all announcements with a

Media coverage

  • Los Angeles Business Journal

    Amgen Sees C-Suite Shifts

    Thousand Oaks pharma giant Amgen Inc. is making a series of C-suite changes, triggered by the retirement announcement of Chief Technology Officer David ...

  • The Globe and Mail

    Amgen Earnings Call Highlights Growth Engines, Tax Risk

    Amgen Inc () has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks. Unlock hedge fund-level...

  • MSN

    FDA pilots real-time trial data review with AstraZeneca, Amgen

    The FDA has launched a pilot program allowing real-time review of clinical trial data, with AstraZeneca and Amgen as the first participants. The initiative aims...

  • MSN

    Merck, Lilly and Amgen unveil major trial and earnings updates

    Merck KGaA has begun Phase III trials of enpatoran for lupus patients with skin symptoms, aiming to address disease mechanisms unmet by current treatments. Eli...

Unlock all articles with a

Never miss news about Amgen

Track Amgen and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Amgen competitors & trending companies

Browse news for competitors to Amgen and other trending companies.